Federated Learning Matches Centralized Cancer AI While Protecting Sensitive Clinical Data

A systematic review evaluating 68 peer-reviewed studies published between January 2019 and August 2026 demonstrates that federated learning allows multi-institutional artificial intelligence to achieve diagnostic accuracy comparable to centralized training across 11 major cancer types while keeping patient records local. Conducted according to PRISMA 2020 guidelines across Google Scholar, PubMed, Web of Science, and Scopus, the survey screened 6,361 candidate publications down to 68 empirical investigations spanning radiological and histopathological cancer imaging. Originally introduced by Google in 2017, federated learning directly confronts stringent data confidentiality mandates such as the European Union’s General Data Protection Regulation, the China Cyber Security Law, and California’s Consumer Privacy Act of 2018. These regulatory frameworks render cross-institutional pooling of raw patient imaging impractical. By iteratively transmitting mathematical model parameters to a central server while retaining raw radiological scans and digital pathology slides within host institutions, federated machine learning mitigates privacy leakage risks while harnessing the collective statistical power of diverse clinical environments.

Within medical applications, federated learning organizes collaborative training across three distinct paradigms determined by how clinical records overlap across sample and feature spaces. Horizontal federated learning applies when participating institutions share identical feature spaces—such as standardized magnetic resonance imaging protocols—but hold distinct patient cohorts, effectively expanding sample volume to counteract localized data scarcity in tasks like multi-center brain tumor segmentation. Conversely, vertical federated learning unites overlapping patient cohorts exhibiting divergent feature modalities, enabling joint modeling between hospital radiological archives and biobank genomic sequences for radiogenomic profiling without direct file transfers. Federated transfer learning accommodates scenarios where participating clinics share neither patient populations nor diagnostic modalities, utilizing domain adaptation mechanisms to facilitate cross-modality knowledge transfer, such as synthesizing magnetic resonance representations from computed tomography scans. Compared to local training, which suffers from sample scarcity, and centralized training, which presents severe data leakage liabilities, federated paradigms coordinate iterative cycles of client fine-tuning and global parameter aggregation until convergence.

In segmentation benchmarks utilizing Multimodal Brain Tumor Segmentation Challenge archives, collaborative frameworks consistently delivered performance matching centralized baselines while demonstrating superior resilience against institutional heterogeneity. Notably, expanding participating hospital nodes from 50 to 100 within a U-Net architecture improved specificity from 0.94 to 0.96 and raised the Dice similarity coefficient from 0.87 to 0.89. Methodological adaptations also successfully resolved specialized operational hurdles: split averaging decomposed neural networks into client and server components to achieve an 84.6 percent Dice score across heterogeneous scans, while clustered federated fine-tuning clustered local radiomic feature vectors, attaining a 0.8874 Dice coefficient. In real-world distributed implementations across five European medical centers using Message Queue Telemetry Transport protocols, asynchronous parameter exchanges reduced training duration by 20 percent while maintaining an 0.85 Dice benchmark.

Representing 10 included publications, lung cancer research demonstrated significant advances across both histopathological subtype classification and computed tomography nodule detection. In histological analyses distinguishing small-cell lung cancer, adenocarcinoma, squamous cell carcinoma, and large-cell carcinoma, federated convolutional models trained across multi-center datasets routinely surpassed 95 percent accuracy. Integrating automated neural architecture search with fuzzy rough modeling produced a 99.96 percent classification benchmark on the LC25000 histopathology dataset, closely matching centralized training. Furthermore, personalized federated autoencoders resolved extreme label-distribution skews under non-independent and identically distributed conditions, retaining perfect 100 percent classification accuracy, sensitivity, and specificity where conventional FedAvg baselines plummeted to 33.3 percent. For computed tomography nodule detection, residual learning frameworks evaluated on clinical datasets from Iraqi hospitals achieved 99.40 percent diagnostic accuracy, substantially exceeding traditional nearest-neighbor baselines. Simultaneously, integrating decentralized blockchain smart contracts with capsule networks established verifiable client anonymity during nodule classification, achieving 99.69 percent detection accuracy across multi-institutional repositories.

Breast cancer represented the most extensive application domain in the survey, encompassing 14 distinct papers addressing histopathology, mammography, ultrasound, and multiparametric magnetic resonance imaging. Across histopathology, homomorphic encryption enabled privacy-preserving model aggregation exceeding independently trained local models by 13.7 percent accuracy on BreakHis data. Novel architectural strategies mitigated institutional variations in staining protocols and tissue scanning hardware without sacrificing patient anonymity: dataset distillation synthesized compact artificial slides to achieve 90.1 percent accuracy on CAMELYON16, federated style transfer preserved diagnostically vital regions while achieving average areas under the curve of 98.11 percent on renal and 86.07 percent on HER2 cohorts, and parameter-efficient prompt tuning reduced transmitted parameters by over 99.9 percent while accelerating convergence up to fourfold. In mammographic density assessment across seven international medical centers, federated deep learning improved classification performance by 6.3 percent over single-institution models. Additionally, real-world deployment across three German university hospitals confirmed cross-institutional segmentation, yielding Dice coefficients of 0.764 for breast tissue and 0.754 for colorectal structures.

Skin cancer research comprised 10 published investigations targeting melanoma, basal cell carcinoma, and squamous cell carcinoma across dermoscopic photography and whole-slide histopathology. Integrating deep learning with open-source federated platforms demonstrated diagnostic efficacy within 8 percent of centralized baselines while protecting sensitive clinical photography. Asynchronous communication designs substantially minimized network latency; updating shallow convolutional feature-extraction layers more frequently than task-specific deep layers enabled models to converge to 93.4 percent classification accuracy in 300 communication rounds, compared to 500 rounds required by synchronous FedAvg. Lightweight packed fully homomorphic encryption combined with stochastic controlled averaging reduced network communication overhead by more than 93 percent while maintaining encrypted inference with less than 2 percent accuracy degradation. Semi-supervised peer learning and self-supervised contrastive learning frameworks effectively leveraged unlabeled imaging data across diverse international skin cohorts, and a prospective multicenter evaluation across six German university hospitals demonstrated that federated melanoma models attained 91.26 percent accuracy on external hospital testing, outperforming centralized alternatives.

Prostate cancer applications accounted for eight studies, focusing on automated magnetic resonance segmentation and clinical risk stratification based on Gleason scoring criteria. In multi-center magnetic resonance segmentation, three-dimensional anisotropic hybrid networks validated across clinical datasets from UCLA, SUNY Upstate, and the National Cancer Institute achieved high internal and external Dice scores of 0.895 and 0.889, surpassing all localized models. Two-stage cascaded segmentation networks distributed across eight clinical facilities attained a 0.84 Dice metric, outperforming centralized learning at 0.77. To resolve scanner-induced data heterogeneity, automated machine learning supernets dynamically selected optimal client architectures, yielding an 87.5 percent cross-institutional Dice score. Concurrently, HarmoFL introduced amplitude normalization to harmonize client-level low-level features while preserving high-level semantic phase information, achieving a 94.28 percent segmentation Dice coefficient. In diagnostic classification, customized feature extractors and variance-aware CycleGAN mappings differentiated intermediate and high-risk malignancies requiring aggressive treatment from indolent lesions warranting observation, achieving classification accuracies up to 98 percent and area-under-the-curve metrics of 0.998.

Beyond the prominent brain, lung, breast, skin, and prostate domains, federated frameworks demonstrated utility across pancreatic, colorectal, liver, thyroid, kidney, and nasopharyngeal imaging. Colorectal histopathology models integrating explainable artificial intelligence and client-dropout techniques attained classification accuracies exceeding 96 percent and area-under-the-curve scores of 0.954. Ultrasound classification of thyroid nodules performed within 5 percent of centralized models, proportional fairness algorithms boosted kidney cancer diagnostic accuracy in data-scarce clinics from 75.3 to 83.5 percent, and federated virtual contrast synthesis generated realistic nasopharyngeal magnetic resonance images across 18 centers without gadolinium contrast agents.

Despite these impressive metrics, methodological analysis of the 68 reviewed papers exposes a significant translational divide between simulated research and genuine clinical deployment. Exactly half of the evaluated studies relied entirely on artificial data partitioning across virtual clients, and 47.1 percent utilized site-based simulations, leaving only six investigations (8.8 percent) validated over genuine distributed hospital infrastructure. Furthermore, only 12 studies (17.6 percent) conducted external validation using independent clinical centers, with the remaining 56 publications relying exclusively on internal test partitions that potentially mask vulnerabilities to scanner-induced domain shifts. Only 10.3 percent implemented differential privacy, 8.8 percent incorporated homomorphic encryption, and 2.9 percent adopted blockchain verification, reflecting concerns that cryptographic defenses introduce burdensome communication overhead while noise injection unavoidably degrades diagnostic precision.

Translating federated learning from retrospective simulations into dependable clinical workflows requires systematically addressing data heterogeneity, communication bottlenecks, governance protocols, and prospective validation. The surveyed evidence highlights that future research must expand beyond common segmentation and classification tasks into multimodal treatment planning, radiotherapy dose estimation, cross-modality synthesis, and integrative radiogenomics. Establishing open, multi-institutional medical imaging benchmarks across underrepresented anatomical regions will also be crucial for reproducible algorithmic development. Ultimately, establishing robust cross-institutional governance, automated audit logging, regulatory compliance infrastructures such as the European Cancer Imaging Initiative, and prospective evaluations in dynamic healthcare settings will determine whether federated learning can transition from academic demonstration to transformative, privacy-preserving cancer medicine.

Subject of Research: Federated learning applications, architectures, and clinical translation in oncology imaging

Article Title: Federated learning in cancer imaging: a comprehensive review and future outlook

Article References: Shi, Y., Li, W., & Cai, J. (2026). Federated learning in cancer imaging: a comprehensive review and future outlook. Frontiers in Radiology, 6, Article 1976540. https://doi.org/10.3389/fradi.2026.1976540

Image Credits: AI Generated

DOI: 10.3389/fradi.2026.1976540

Keywords: federated learning, cancer imaging, medical artificial intelligence, deep learning, differential privacy, homomorphic encryption, brain tumor segmentation, histopathology, computed tomography, magnetic resonance imaging, breast cancer classification, skin cancer detection, prostate cancer grading, pancreatic tumor segmentation, data heterogeneity, dataset distillation, personalized federated learning, clinical translation